AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Credage MV 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Abseil Pharmaceticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Credage MV 1mg/500mg/0.2mg Tablet

Diabetace Control 1mg/500mg/0.2mg tablets are classified as anti-diabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, effectively regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as discontinuation without medical guidance can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, characterized by sweating, dizziness, headache, and tremors. Prompt recognition and treatment are vital; maintain regular meals and carry a fast-acting glucose source like sugary snacks or juice. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects encompass altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or significant kidney or liver impairment. Prior heart disease should be disclosed to your doctor before initiating treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Credage MV 1mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Credage MV 1mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Credage MV 1mg/500mg/0.2mg Tablet whole; do not break, crush, or chew it. Administer on an empty stomach.

Common Side effects of Credage MV 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Credage MV 1mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Credage MV 1mg/500mg/0.2mg Tablet whole; do not break, crush, or chew it. Administer on an empty stomach.

How Credage MV 1mg/500mg/0.2mg Tablet works:

Each Credage MV tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Credage MV 1mg/500mg/0.2mg tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Credage MV 1mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Credage MV 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary data from human studies indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Credage MV 1mg/500mg/0.2mg Tablets, as their use may be unsafe. Medical advice is recommended. Furthermore, this medication is unsuitable for individuals with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Credage MV 1mg/500mg/0.2mg Tablets cautiously, as dose modification may be necessary. A physician's consultation is advised. In those with mild to moderate liver disease, initiation should be at a reduced dosage; the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Credage MV 1mg/500mg/0.2mg Tablet :

Should you forget a Credage MV 1mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Credage MV 1mg/500mg/0.2mg Tablet

LabelValue
Addictive None.
Treatment Category Medication for diabetes

FAQs on Credage MV 1mg/500mg/0.2mg Tablet

Credage MV 1mg/500mg/0.2mg tablets contain glimepiride, metformin, and voglibose. This triple-drug formulation manages type 2 diabetes mellitus by improving glycemic control in adults when combined with dietary adjustments and physical activity. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood sugar levels. This medication is unsuitable for type 1 diabetes mellitus.
Patients taking Credage MV 1mg/500mg/0.2mg tablets may experience common adverse events including low blood glucose, nausea, diarrhea, taste disturbances, gas, abdominal pain, headache, skin eruptions, and respiratory illness.
Patients with hypersensitivity to any ingredient or inactive component in Credage MV 1mg/500mg/0.2mg Tablets should not take this medication. Furthermore, its administration is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel disorders, colonic ulcers, and pre-existing metabolic acidosis, encompassing diabetic ketoacidosis.
Combining Credage MV 1mg/500mg/0.2mg tablets and alcohol is unsafe. This combination could lead to dangerously low blood sugar (hypoglycemia) and a heightened risk of lactic acidosis.
Indeed, Credage MV 1mg/500mg/0.2mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar can encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of unease or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic agents. Therefore, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Retain this medication within its original, sealed packaging. Follow the storage guidelines printed on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, animals, and others.
Credage MV 1mg/500mg/0.2m...
74
MRP 90
17% off